These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Effects of pioglitazone and retinoic acid in a rotenone model of Parkinson's disease. Ulusoy GK; Celik T; Kayir H; Gürsoy M; Isik AT; Uzbay TI Brain Res Bull; 2011 Jul; 85(6):380-4. PubMed ID: 21600965 [TBL] [Abstract][Full Text] [Related]
24. Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease. Xue YQ; Zhao LR; Guo WP; Duan WM Neuroscience; 2007 May; 146(3):1245-58. PubMed ID: 17363174 [TBL] [Abstract][Full Text] [Related]
25. A Nurr1 agonist causes neuroprotection in a Parkinson's disease lesion model primed with the toll-like receptor 3 dsRNA inflammatory stimulant poly(I:C). Smith GA; Rocha EM; Rooney T; Barneoud P; McLean JR; Beagan J; Osborn T; Coimbra M; Luo Y; Hallett PJ; Isacson O PLoS One; 2015; 10(3):e0121072. PubMed ID: 25815475 [TBL] [Abstract][Full Text] [Related]
26. Pramipexole but not imipramine or fluoxetine reverses the "depressive-like" behaviour in a rat model of preclinical stages of Parkinson's disease. Berghauzen-Maciejewska K; Kuter K; Kolasiewicz W; Głowacka U; Dziubina A; Ossowska K; Wardas J Behav Brain Res; 2014 Sep; 271():343-53. PubMed ID: 24956561 [TBL] [Abstract][Full Text] [Related]
27. Serotonin₆ receptors in the dorsal hippocampus regulate depressive-like behaviors in unilateral 6-hydroxydopamine-lesioned Parkinson's rats. Liu KC; Li JY; Tan HH; Du CX; Xie W; Zhang YM; Ma WL; Zhang L Neuropharmacology; 2015 Aug; 95():290-8. PubMed ID: 25863121 [TBL] [Abstract][Full Text] [Related]
28. Influence of enrichment on behavioral and neurogenic effects of antidepressants in Wistar rats submitted to repeated forced swim test. Possamai F; dos Santos J; Walber T; Marcon JC; dos Santos TS; Lino de Oliveira C Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():15-21. PubMed ID: 25485962 [TBL] [Abstract][Full Text] [Related]
29. Hippocampal VEGF is necessary for antidepressant-like behaviors but not sufficient for antidepressant-like effects of ketamine in rats. Choi M; Lee SH; Chang HL; Son H Biochim Biophys Acta; 2016 Jul; 1862(7):1247-54. PubMed ID: 27063455 [TBL] [Abstract][Full Text] [Related]
30. Melatonin synergizes with citalopram to induce antidepressant-like behavior and to promote hippocampal neurogenesis in adult mice. Ramírez-Rodríguez G; Vega-Rivera NM; Oikawa-Sala J; Gómez-Sánchez A; Ortiz-López L; Estrada-Camarena E J Pineal Res; 2014 May; 56(4):450-61. PubMed ID: 24650119 [TBL] [Abstract][Full Text] [Related]
31. Activin A protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson's disease. Stayte S; Rentsch P; Li KM; Vissel B PLoS One; 2015; 10(4):e0124325. PubMed ID: 25902062 [TBL] [Abstract][Full Text] [Related]
32. Post-lesion administration of 7-NI attenuated motor and non-motor deficits in 6-OHDA induced bilaterally lesioned female rat model of Parkinson's disease. Kumari R; Kumar JB; Luthra PM Neurosci Lett; 2015 Mar; 589():191-5. PubMed ID: 25528406 [TBL] [Abstract][Full Text] [Related]
33. New Hippocampal Neurons Mature Rapidly in Response to Ketamine But Are Not Required for Its Acute Antidepressant Effects on Neophagia in Rats. Soumier A; Carter RM; Schoenfeld TJ; Cameron HA eNeuro; 2016; 3(2):. PubMed ID: 27066531 [TBL] [Abstract][Full Text] [Related]
34. Beneficial effect of etazolate on depression-like behavior and, learning, and memory impairment in a model of Parkinson's disease. Alzoubi KH; Mokhemer E; Abuirmeileh AN Behav Brain Res; 2018 Sep; 350():109-115. PubMed ID: 29758248 [TBL] [Abstract][Full Text] [Related]
35. AAV2-mediated striatum delivery of human CDNF prevents the deterioration of midbrain dopamine neurons in a 6-hydroxydopamine induced parkinsonian rat model. Ren X; Zhang T; Gong X; Hu G; Ding W; Wang X Exp Neurol; 2013 Oct; 248():148-56. PubMed ID: 23764500 [TBL] [Abstract][Full Text] [Related]
37. Liver X receptor β in the hippocampus: A potential novel target for the treatment of major depressive disorder? Peng Z; Deng B; Jia J; Hou W; Hu S; Deng J; Lin W; Hou L; Sang H Neuropharmacology; 2018 Jun; 135():514-528. PubMed ID: 29654801 [TBL] [Abstract][Full Text] [Related]
38. Antidepressant-like effect of the water extract of the fixed combination of Gardenia jasminoides, Citrus aurantium and Magnolia officinalis in a rat model of chronic unpredictable mild stress. Xing H; Zhang K; Zhang R; Shi H; Bi K; Chen X Phytomedicine; 2015 Dec; 22(13):1178-85. PubMed ID: 26598917 [TBL] [Abstract][Full Text] [Related]
39. Neuroprotective effect of curcumin on hippocampal injury in 6-OHDA-induced Parkinson's disease rat. Yang J; Song S; Li J; Liang T Pathol Res Pract; 2014 Jun; 210(6):357-62. PubMed ID: 24642369 [TBL] [Abstract][Full Text] [Related]
40. Role of the locus coeruleus catecholaminergic neurons in the chemosensory control of breathing in a Parkinson's disease model. Oliveira LM; Tuppy M; Moreira TS; Takakura AC Exp Neurol; 2017 Jul; 293():172-180. PubMed ID: 28431876 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]